Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
Department of Pediatrics, National Cardiovascular Center, Suita-shi, Osaka, Japan. etsuda@hsp.ncvc.go.jp
Etsuko
E
Tsuda
Mai
M
Matsuo
Heima
H
Sakaguchi
Tamaki
T
Hayashi
Kazutaka
K
Hosoda
Aya
A
Miyazaki
D000293:Adolescent; D000638:Amiodarone / Q000008:administration & dosage* / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002227:Carbazoles / Q000008:administration & dosage* / Q000009:adverse effects; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000188:drug therapy; D000077261:Carvedilol; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005665:Furosemide / Q000008:administration & dosage / Q000009:adverse effects; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood; D011412:Propanolamines / Q000008:administration & dosage* / Q000009:adverse effects; D012008:Recurrence; D013148:Spironolactone / Q000008:administration & dosage / Q000009:adverse effects; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D002227:Carbazoles; D011412:Propanolamines; D014665:Vasodilator Agents; D000077261:Carvedilol; D020097:Natriuretic Peptide, Brain; D013148:Spironolactone; D005665:Furosemide; D000638:Amiodarone